Literature DB >> 9874185

Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis.

Y Sato1, Y Honda, T Asoh, K Oizumi, Y Ohshima, E Honda.   

Abstract

Ferritin concentrations in cerebrospinal fluid (CSF) of 16 patients with glioblastoma were found to be very high (mean, 103.0 ng/mL) relative to 29 patients with viral meningitis and 20 patients with headache (mean concentrations, 5.4 and 4.3 ng/mL respectively). Simultaneous measurement of ferritin in CSF and serum revealed CSF concentrations exceeding those in serum in 11 of 16 patients with glioblastoma (CSF vs. serum ratio, 132.6%), contrasting with very low ratios in patients with meningitis (7.9%) or headache (4.9%). Ferritin was detected immunocytochemically in tumor cell cytoplasm in a resected glioblastoma. Thus, ferritin in CSF appears to be produced by glioblastoma cells, with a biologic significance requiring further investigation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9874185     DOI: 10.1023/a:1006078521790

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

Review 1.  Ferritin in serum. Clinical and biochemical implications.

Authors:  A Jacobs; M Worwood
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

2.  Cerebrospinal fluid ferritin in human disease.

Authors:  E Zappone; V Bellotti; M Cazzola; M Ceroni; F Meloni; P Pedrazzoli; V Perfetti
Journal:  Haematologica       Date:  1986 Mar-Apr       Impact factor: 9.941

3.  Cerebrospinal fluid ferritin in malignant CNS involvement.

Authors:  G Zandman-Goddard; Y Matzner; A M Konijn; C Hershko
Journal:  Cancer       Date:  1986-09-15       Impact factor: 6.860

4.  Cerebrospinal fluid ferritin levels in screening for meningism.

Authors:  D R Campbell; B S Skikne; J D Cook
Journal:  Arch Neurol       Date:  1986-12

5.  Synthesis and localization of plasma proteins in the developing human brain. Integrity of the fetal blood-brain barrier to endogenous proteins of hepatic origin.

Authors:  K Møllgård; K M Dziegielewska; N R Saunders; H Zakut; H Soreq
Journal:  Dev Biol       Date:  1988-07       Impact factor: 3.582

6.  Development of ferritin-positive cells in cerebrum of human brain.

Authors:  H Ozawa; A Nishida; T Mito; S Takashima
Journal:  Pediatr Neurol       Date:  1994-02       Impact factor: 3.372

7.  Ferritinaemia in cancer.

Authors:  J T Hazard; J W Drysdale
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

8.  Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change.

Authors:  J A Royds; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-12       Impact factor: 10.154

9.  The clinical relevance of ferritin concentration in the cerebrospinal fluid.

Authors:  C J Sindic; D Collet-Cassart; C L Cambiaso; P L Masson; E C Laterre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

10.  Cerebrospinal fluid ferritin in patients with cerebral infarction or bleeding.

Authors:  R Hällgren; A Terent; L Wide; K Bergström; G Birgegård
Journal:  Acta Neurol Scand       Date:  1980-06       Impact factor: 3.209

View more
  9 in total

1.  Expression and hypoxic up-regulation of neuroglobin in human glioblastoma cells.

Authors:  Marwan Emara; Nicole Salloum; Joan Allalunis-Turner
Journal:  Mol Oncol       Date:  2008-12-12       Impact factor: 6.603

2.  Proteins with altered levels in plasma from glioblastoma patients as revealed by iTRAQ-based quantitative proteomic analysis.

Authors:  Poonam Gautam; Sudha C Nair; Manoj Kumar Gupta; Rakesh Sharma; Ravindra Varma Polisetty; Megha S Uppin; Challa Sundaram; Aneel K Puligopu; Praveen Ankathi; Aniruddh K Purohit; Giriraj R Chandak; H C Harsha; Ravi Sirdeshmukh
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

3.  Liquid biopsies in patients with diffuse glioma.

Authors:  Myron G Best; Nik Sol; Sebastiaan Zijl; Jaap C Reijneveld; Pieter Wesseling; Thomas Wurdinger
Journal:  Acta Neuropathol       Date:  2015-02-27       Impact factor: 17.088

4.  Alterations in the basal ganglia in patients with brain tumours may be due to excessive iron deposition.

Authors:  Vít Herynek; Dita Wagnerová; Alberto Malucelli; Josef Vymazal; Martin Sameš; Milan Hájek
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

5.  Basal Ganglia Iron Content Increases with Glioma Severity Using Quantitative Susceptibility Mapping: A Potential Biomarker of Tumor Severity.

Authors:  Thomas P Reith; Melissa A Prah; Eun-Jung Choi; Jongho Lee; Robert Wujek; Mona Al-Gizawiy; Christopher R Chitambar; Jennifer M Connelly; Kathleen M Schmainda
Journal:  Tomography       Date:  2022-03-15

Review 6.  Emerging roles of ferroptosis in glioma.

Authors:  Jiaqi Shi; Ning Yang; Mingzhi Han; Chen Qiu
Journal:  Front Oncol       Date:  2022-08-22       Impact factor: 5.738

Review 7.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

8.  SELDI-TOF analysis of glioblastoma cyst fluid is an approach for assessing cellular protein expression.

Authors:  Martin Hoelscher; Nina Richter; Christian Melle; Ferdinand von Eggeling; Anne Schaenzer; Ulf Nestler
Journal:  Neurol Res       Date:  2013-12       Impact factor: 2.448

9.  Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approach.

Authors:  Klemen Zupancic; Andrej Blejec; Ana Herman; Matija Veber; Urska Verbovsek; Marjan Korsic; Miomir Knezevic; Primoz Rozman; Tamara Lah Turnsek; Kristina Gruden; Helena Motaln
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.